Abstract
As the central component of the complement system, C3 has sensory and effector functions bridging innate and adaptive immunity. It is plausible that common genetic variation at C3 determines either serum C3 level or susceptibility to systemic lupus erythematosus (SLE), but only a single, Japanese, study has currently showed genetic association. In a cohort of 1371 individuals from 393 UK white European SLE families, we quantified serum C3 and genotyped C3 tagSNPs. Using a Bayesian variance components model, we estimated 39.6% serum C3 heritability. Genotype/serum C3 association was determined by mixed linear models. Single nucleotide polymorphism (SNP) rs344555, located in a haplotype block incorporating the 3′ end of C3, was associated with serum C3 (P=0.007), with weaker associations observed for other SNPs in this block. In an extended cohort of 585 SLE families the association between C3 variants and SLE was assessed by transmission disequilibrium test. SNP rs3745568 was associated with SLE (P=0.0046), but not with serum C3. Our disease associated SNP differs from that highlighted in the Japanese study; however, we replicate their finding that genetic variants at the 3′ end of C3 are associated with serum C3. Larger studies and further fine mapping will be required to definitively identify functional variants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Walport MJ . Complement. First of two parts. N Engl J Med 2001; 344: 1058–1066.
Casciola-Rosen LA, Anhalt G, Rosen A . Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317–1330.
Mevorach D, Mascarenhas JO, Gershov D, Elkon KB . Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998; 188: 2313–2320.
Pittoni V, Valesini G . The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev 2002; 1: 154–161.
Schifferli JA, Woo P, Peters DK . Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol 1982; 47: 555–562.
Schifferli JA, Ng YC, Estreicher J, Walport MJ . The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol 1988; 140: 899–904.
Rhodes B, Vyse TJ . The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 2008; 47: 1603–1611.
Manderson AP, Botto M, Walport MJ . The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22: 431–456.
Yang Y, Chung EK, Wu YL, Savelli SL, Najaraja HN, Zhou B et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007; 80: 1037–1054.
Fernando MM, Stevens CR, Sabeti PC, Walsh EC, McWhinnie AJ, Shah A et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007; 3: e192.
Reis S, Falcao DA, Isaac L . Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 2006; 63: 155–168.
Miyagawa H, Yamai M, Sakaguchi D, Kiyohara C, Tsukamoto H, Kimoto Y et al. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 2008; 47: 158–164.
Hunnangkul S, Nitsch D, Rhodes B, Chadha S, Roberton CA, Pessoa-Lopes P et al. Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1116–1124.
de Lange M, Sneider H, Ariens RAS, Spector TD, Grant JG . The genetics of haemostasis:a twin study. Lancet 2001; 357: 101–105.
Fox ER, Benjamin EJ, Sarpong DF, Rotimi CN, Wilson JG, Steffes MW et al. Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study). Am J Cardiol 2008; 102: 835–841.
Rhodes B, Meek J, Whittaker JC, Vyse TJ . Quantification of the genetic component of basal C-reactive protein expression in SLE nuclear families. Ann Hum Genet 2008; 72: 611–620.
Inoue H, Mashimo Y, Funamizu M, Shimojo N, Hasegawa K, Hirota T et al. Association study of the C3 gene with adult and childhood asthma. J Hum Genet 2008; 53: 728–738.
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225–2229.
Ross P, Hall L, Smirnov I, Haff L . High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 1998; 16: 1347–1351.
O’Connell JR, Weeks DE . PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259–266.
Mancini G, Carbonara AO, Heremans JF . Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235–254.
Burton PR, Tiller KJ, Gurrin LC, Cookson WO, Musk AW, Palmer LJ . Genetic variance components analysis for binary phenotypes using generalized linear mixed models (GLMMs) and Gibbs sampling. Genet Epidemiol 1999; 17: 118–140.
Lunn DJ, Thomas A, Best N, Spiegelhalter D . WinBUGS—a Bayesian modelling framework: concepts, structure and extensibility. Stat Comput 2000; 10: 325–337.
Clayton D . A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170–1177.
Browning BL, Browning SR . A unified approach to genotype imputation and haplotype phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet 2009; 84: 210–223.
Browning SR, Browning BL . Rapid and accurate haplotype phasing and missing data inference for whole genome association studies using localized haplotype clustering. Am J Hum Genet 2007; 81: 1084–1097.
Browning BL, Browning SR . Efficient multilocus association testing for whole genome association studies using localized haplotype clustering. Genet Epidemiol 2007; 31: 365–375.
Acknowledgements
We would like to thank the study patients and their families for participating in this research, along with clinical colleagues who facilitated data collection. In particular, we thank Peter Norsworthy for his assistance with the C3 radial immunodiffusion assays. This work was funded by the Arthritis Research Campaign Clinical Research Fellowship (B Rhodes) and the Wellcome Trust Senior Fellowship (TJ Vyse). We are grateful for support from the NIHR Biomedical Research Centre funding scheme and for the NIH support P01 AI065687-03.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rhodes, B., Hunnangkul, S., Morris, D. et al. The heritability and genetics of complement C3 expression in UK SLE families. Genes Immun 10, 525–530 (2009). https://doi.org/10.1038/gene.2009.23
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2009.23
Keywords
This article is cited by
-
Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype
Scientific Reports (2020)
-
Complement C3 gene polymorphisms are associated with lipid levels, but not the risk of coronary artery disease: a case-control study
Lipids in Health and Disease (2019)
-
The role of the alternative pathway of complement activation in glomerular diseases
Clinical and Experimental Medicine (2018)
-
Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis
The Pharmacogenomics Journal (2017)
-
Copy number variations and gene polymorphisms of Complement components in ocular Behcet’s disease and Vogt-Koyanagi-Harada syndrome
Scientific Reports (2015)